Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene Lotion in the Treatment of Plaque Psoriasis

INTRODUCTION: To date, there have been no head-to-head clinical studies comparing calcipotriol 0.005% plus betamethasone dipropionate 0.064% (Cal/BD) aerosol foam and halobetasol propionate 0.01% plus tazarotene 0.045% (HP/Taz) lotion for the treatment of plaque psoriasis. However, the efficacy of 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, David N., Jablonski Bernasconi, Marie Y., Thoning, Henrik, Wu, Jashin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588120/
https://www.ncbi.nlm.nih.gov/pubmed/36223060
http://dx.doi.org/10.1007/s13555-022-00824-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588120/
https://www.ncbi.nlm.nih.gov/pubmed/36223060
http://dx.doi.org/10.1007/s13555-022-00824-9

Ejemplares similares